A PHASE 1/2A STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRATHECALLY ADMINISTERED ION717 IN PATIENTS WITH PRION DISEASE

Registry ID

ION717-CS2

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

IONIS PHARMACEUTICALS INC

Start date

2024-01-23

Last update

2023-05-11

Conditions

• PRION DISEASE

View on source registry